Methodology

All entries for: Insmed INC

February 19, 2026

Insmed INC

Neutral Outlook

Bridgewater, NJ

1,001-5,000 employees

We cannot predict other potential implications the IRA provisions will have on our business or the pricing of our product candidates, if approved.

Disease Area: Chronic Disease, Immune Diseases, Neurological Diseases, Other, Respiratory Diseases

Drug Type: Biologic, Small Molecule

Source

February 19, 2026

Insmed INC

Negative Outlook

Bridgewater, NJ

1,001-5,000 employees

Additionally, if our products are deemed subject to GUARD, we may determine to forego commercializing our products outside of the US, which may adversely affect our business.

Source